THU0202 Comparative effectiveness of tocilizumab as monotherapy versus tnf inhibitors in combination with conventional synthetic disease modifying antirheumatic drugs in bio-naÏve patients with rheumatoid arthritis

K. Lauper; T. K. Kvien; C. Codreanu; M. V. Hernandez; F. Ianonne; E. K. Kristianslund; G. Lukina; D. C. Nordstrom; K. Pavelka; Z. Rotar; M. J. Santos; S. L. Gale; M. John; Y. Luder; D. S. Courvoisier; C. Gabay

doi:10.1136/annrheumdis-2018-eular.1606

THU0202 Comparative effectiveness of tocilizumab as monotherapy versus tnf inhibitors in combination with conventional synthetic disease modifying antirheumatic drugs in bio-naÏve patients with rheumatoid arthritis

K. Lauper, T. K. Kvien, C. Codreanu, M. V. Hernandez, F. Ianonne, E. K. Kristianslund, G. Lukina, D. C. Nordstrom, K. Pavelka, Z. Rotar, M. J. Santos, S. L. Gale, M. John, Y. Luder, D. S. Courvoisier, C. Gabay

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	THU0202
Pages (from-to)	320-321
Number of pages	2
Journal	Annals of the rheumatic diseases
Volume	77
DOIs	https://doi.org/10.1136/annrheumdis-2018-eular.1606
Publication status	Published - Jun 2018
Externally published	Yes

Access to Document

10.1136/annrheumdis-2018-eular.1606

Cite this

Lauper, K., Kvien, T. K., Codreanu, C., Hernandez, M. V., Ianonne, F., Kristianslund, E. K., Lukina, G., Nordstrom, D. C., Pavelka, K., Rotar, Z., Santos, M. J., Gale, S. L., John, M., Luder, Y., Courvoisier, D. S., & Gabay, C. (2018). THU0202 Comparative effectiveness of tocilizumab as monotherapy versus tnf inhibitors in combination with conventional synthetic disease modifying antirheumatic drugs in bio-naÏve patients with rheumatoid arthritis. Annals of the rheumatic diseases, 77, 320-321. Article THU0202. https://doi.org/10.1136/annrheumdis-2018-eular.1606

@article{c4c8b6160a654cebbee9f41cf965fab1,

title = "THU0202 Comparative effectiveness of tocilizumab as monotherapy versus tnf inhibitors in combination with conventional synthetic disease modifying antirheumatic drugs in bio-na{\"I}ve patients with rheumatoid arthritis",

author = "K. Lauper and Kvien, {T. K.} and C. Codreanu and Hernandez, {M. V.} and F. Ianonne and Kristianslund, {E. K.} and G. Lukina and Nordstrom, {D. C.} and K. Pavelka and Z. Rotar and Santos, {M. J.} and Gale, {S. L.} and M. John and Y. Luder and Courvoisier, {D. S.} and C. Gabay",

year = "2018",

month = jun,

doi = "10.1136/annrheumdis-2018-eular.1606",

language = "English",

volume = "77",

pages = "320--321",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "Elsevier BV",

}

Lauper, K, Kvien, TK, Codreanu, C, Hernandez, MV, Ianonne, F, Kristianslund, EK, Lukina, G, Nordstrom, DC, Pavelka, K, Rotar, Z, Santos, MJ, Gale, SL, John, M, Luder, Y, Courvoisier, DS & Gabay, C 2018, 'THU0202 Comparative effectiveness of tocilizumab as monotherapy versus tnf inhibitors in combination with conventional synthetic disease modifying antirheumatic drugs in bio-naÏve patients with rheumatoid arthritis', Annals of the rheumatic diseases, vol. 77, THU0202, pp. 320-321. https://doi.org/10.1136/annrheumdis-2018-eular.1606

THU0202 Comparative effectiveness of tocilizumab as monotherapy versus tnf inhibitors in combination with conventional synthetic disease modifying antirheumatic drugs in bio-naÏve patients with rheumatoid arthritis. / Lauper, K.; Kvien, T. K.; Codreanu, C. et al.
In: Annals of the rheumatic diseases, Vol. 77, THU0202, 06.2018, p. 320-321.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - THU0202 Comparative effectiveness of tocilizumab as monotherapy versus tnf inhibitors in combination with conventional synthetic disease modifying antirheumatic drugs in bio-naÏve patients with rheumatoid arthritis

AU - Lauper, K.

AU - Kvien, T. K.

AU - Codreanu, C.

AU - Hernandez, M. V.

AU - Ianonne, F.

AU - Kristianslund, E. K.

AU - Lukina, G.

AU - Nordstrom, D. C.

AU - Pavelka, K.

AU - Rotar, Z.

AU - Santos, M. J.

AU - Gale, S. L.

AU - John, M.

AU - Luder, Y.

AU - Courvoisier, D. S.

AU - Gabay, C.

PY - 2018/6

Y1 - 2018/6

UR - http://www.mendeley.com/research/thu0202-comparative-effectiveness-tocilizumab-monotherapy-versus-tnf-inhibitors-combination-conventi

U2 - 10.1136/annrheumdis-2018-eular.1606

DO - 10.1136/annrheumdis-2018-eular.1606

M3 - Meeting Abstract

SN - 0003-4967

VL - 77

SP - 320

EP - 321

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

M1 - THU0202

ER -

Lauper K, Kvien TK, Codreanu C, Hernandez MV, Ianonne F, Kristianslund EK et al. THU0202 Comparative effectiveness of tocilizumab as monotherapy versus tnf inhibitors in combination with conventional synthetic disease modifying antirheumatic drugs in bio-naÏve patients with rheumatoid arthritis. Annals of the rheumatic diseases. 2018 Jun;77:320-321. THU0202. doi: 10.1136/annrheumdis-2018-eular.1606

THU0202 Comparative effectiveness of tocilizumab as monotherapy versus tnf inhibitors in combination with conventional synthetic disease modifying antirheumatic drugs in bio-naÏve patients with rheumatoid arthritis

Access to Document

Other files and links

Cite this